The Omnibus Transportation Employee Testing Act of 1991 mandated the Secretary of Transportation to issue regulations to combat prohibited drug use and alcohol misuse in the transportation industry. For that portion of the transportation industry having to do with the provision of and service to the public of “mass transportation,” the FTA is the agency delegated with the authority and responsibility for issuing these implementing rules. These rules are encompassed in 49 CFR Part 655, Prevention of Alcohol Misuse and Prohibited Drug Use in Transit Operations.
- The 12th Annual FTA Drug and Alcohol Program National Conference will be held at the Hilton New Orleans Riverside April 18-20, 2017. Register today!
- FTA's Drug and Alcohol Regulation Updates Newsletter issue #60 has been published.
- See FTA's Drug and Alcohol Policy Builder that helps transit agencies develop customized anti-drug and alcohol misuse policies that are compliant with FTA regulations.
- Implementation of the 2014 Federal Custody and Control Form (CCF) and HHS/NLCP guidance for the eCCF form
- View updates to the Substance Abuse One-Day Seminar Schedule.
Office of Drug and Alcohol Policy and Compliance Updates
- 2016 DOT Random Testing Rates Notice
- The Office of Drug and Alcohol Policy and Compliance has published an updated DOT Urine Specimen Collection Guidelines for the U.S. Department of Transportation Workplace Drug Testing Programs (49 CFR Part 40). This update includes:
- Updated web site addresses/hyperlinks,
- Modified language throughout the document to clarify concepts and to identify when actions are required versus simply permitted by the regulation. These edits are italicized throughout this document and the items italicized, underlined, and bolded from the 2010 revisions to this document were returned to normal text,
- Removed effective dates in Section 4 that have passed,
- Section 13 was re-organized,
- Removed Section 14
- ODAPC has issued a notice regarding the use of recreational marijuana.
- ODAPC has issued a notice regarding the use of medical marijuana.
A final rule, effective June 25, 2013, was issued to revise sections of 49 CFR Part 655.